Symbols

VTYX(Delisted)

Ventyx Biosciences·NASDAQ

--(--)

5.32 / 10

Netural

Fund flow analysis scores 7.2/10, indicating robust fund flow characteristics. Bullish trends in Small contrast with bearish signals in overall, block, Medium, Large, and Extra-large, suggesting positive liquidity momentum. Research analyst consensus shows cautiously optimistic analyst perspective, demonstrating balanced view. Current ratings: Strong Buy(14.3%), Neutral(85.7%) across 7 coverage providers, supported by 3.44 historical weighted rating.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

14%

Buy

Hold

Sell

Strong Sell

Date2026-01-08

InstitutionWells Fargo

Times predicted2

Historical Win Rate100.0%

What is the analyst consensus for VTYX?

VTYX holds a Bearish analyst rating, with 14% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.32/10 (Netural).